ArticleNanomaterials (Basel, Switzerland)2018
Mechanical and Sorptivity Characteristics of Edge-Oxidized Graphene Oxide (EOGO)-Cement Composites: Dry- and Wet-Mix Design Methods.
Article in Nanomaterials (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Multi-objective optimization of low-noise pervious concrete using a stacking ensemble learning and NSGA-II approach.Scientific reports · 2026Article
- Effects of EOGO in Metakaolin-Based Geopolymer.Materials (Basel, Switzerland) · 2025Article
- Effect of Edge-Oxidized Graphene Oxide (EOGO) on Fly Ash Geopolymer.Materials (Basel, Switzerland) · 2025Article
- A Study on the Effect of Graphene Oxide on Geotechnical Properties of Soil.Materials (Basel, Switzerland) · 2024Article
- Article
- Rheological and Flexural Strength Characteristics of Cement Mixtures through the Synergistic Effects of Graphene Oxide and PVA Fibers.Polymers · 2024Article
- Enhancing Cementitious Composites with Functionalized Graphene Oxide-Based Materials: Surface Chemistry and Mechanisms.International journal of molecular sciences · 2023Review
- Molecular Dynamics Simulation of Calcium-Silicate-Hydrate for Nano-Engineered Cement Composites-A Review.Nanomaterials (Basel, Switzerland) · 2020Review
- Recent Progress in Nanomaterials for Modern Concrete Infrastructure: Advantages and Challenges.Materials (Basel, Switzerland) · 2019Review
- Electrochemical Characterization and Inhibiting Mechanism on Calcium Leaching of Graphene Oxide Reinforced Cement Composites.Nanomaterials (Basel, Switzerland) · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This paper aims to investigate the effects of edge-oxidized graphene oxide nanoflakes (EOGO) on the mechanical properties and sorptivity of cement composites. The EOGO used in this study was produced by a mechanochemical process that assists the production of EOGO in large quantities at significantly reduced costs, enabling its practical use for infrastructure construction. The scope of this work includes the use of EOGO as an additive in cement composites, including cement paste and mortar. This study explores two mixing methods: The dry-mix method and the wet-mix method. The dry-mix method uses EOGO as dry powder in cement composites whereas the wet-mix method uses a water-dispersed solution (using a sonication process). Varied percentages of EOGO, ranging from 0.01% to 1.0%, were used for both methods. To evaluate the concrete durability, the effect of EOGO addition on sorptivity of the cement composites was investigated by performing total porosity and water sorptivity tests. It was found that 0.05% of EOGO is the optimum proportion to exert the highest strength in compressive and flexural strength tests. In addition, the dry-mix method is comparable to the wet-mix method (with dispersion of EOGO), thus more practical for field engineering applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.